ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
Summarize this article with:
SA Transcripts157.58K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call January 9, 2026 9:00 AM EST Company Participants P. F. Te Boekhorst - President, CEO & DirectorTimothy Fiori - CFO, Secretary, Treasurer & DirectorJonathan RothschildMichael Brigham - Special Advisor to the CEO & Director Conference Call Participants Joe Diaz - Lytham Partners, LLCFrank GascaDavid Champoux - Pierce Atwood LLPGeorge Melas - MKH Management Company, LLCRussell Tolander - Capital Alliance Corporation Presentation Operator Good morning, everyone, and welcome to the ImmuCell Corporation conference call to discuss strategic change in focus and unaudited 2025 sales results. [Operator Instructions] Please also note, today's event is being recorded. At this time, I'd like to turn the floor over to Joe Diaz with Lytham Partners. Please go ahead. Joe DiazLytham Partners, LLC Thank you, Jamie. Good morning, and welcome. As our operator indicated, my name is Joe Diaz with Lytham Partners. We're the Investor Relations consulting firm for ImmuCell. I thank all of you for joining us today to discuss the change in ImmuCell's strategic focus and the unaudited sales results for the fourth quarter and full year December 31, 2025. Listeners are reminded and caution that statements made by management during the course of this call include forward-looking statements, which include any statement that refers to future events or expected future results or predictions about steps the company plans to take in the future. These statements are not guarantees of performance and are subject to risks and uncertainties that could cause actual results, outcomes or events to differ materially from those discussed today. Additional information regarding forward-looking statements and the risks and uncertainties that could impact future results, outcomes or events is available under the cautionary note regarding forward-looking statements or the safe harbor statement provided with the press release that the company filed last night, along with the company's other periodic filings with the SEC.